Albumin-Bound Paclitaxel: all 674 studies that test it
Page 7 of 7. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- S-1 in Combination With Abraxane in Treating CholangiocarcinomaCompletedNCT01963325Phase 2
- Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic CancerStatus unknownNCT01934634Phase 1
- Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic MelanomaWithdrawnNCT01933061Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the LungStatus unknownNCT01872403Phase 2
- Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01858883Phase 1/2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
- IST Neoadjuvant Abraxane in Newly Diagnosed Breast CancerStatus unknownNCT01830244Phase 2
- Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast CancerCompletedNCT01822314Phase 3
- Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast CancerCompletedNCT01763710Phase 2
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic CancerCompletedNCT01715142Early Phase 1
- Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic CancerTerminatedNCT01693276Phase 1/2
- Study of Nab-Paclitaxel in High Risk Early Breast CancerCompletedNCT01690702Phase 3
- Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid MalignanciesCompletedNCT01677559Phase 1
- A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT01676259Phase 2
- Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical CancerStatus unknownNCT01667211Phase 2
- Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01647672Phase 2/3
- Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer PatientsStatus unknownNCT01641783Phase 2
- Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast CancerStatus unknownNCT01625429Phase 2
- Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)CompletedNCT01583426Phase 3
- Phase I/II Study of Abraxane in Recurrent and Refractory LymphomaTerminatedNCT01555853Phase 1
- A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast CancerCompletedNCT01550848Phase 2
- Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerCompletedNCT01488552Phase 1/2
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic CancerCompletedNCT01442974Not applicable
- Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and TrastuzumabCompletedNCT01432223Phase 2
- Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)TerminatedNCT01416558Phase 2
- Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer PatientsCompletedNCT01336062Phase 1/2
- Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic CancerCompletedNCT01298011Phase 2
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
- Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the BreastCompletedNCT01204437Phase 2/3
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01189929Phase 1
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- A Combination of Abraxane and Cisplatin in Metastatic Breast CancerCompletedNCT01149798Phase 2
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast CancerTerminatedNCT01090128Phase 1
- HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast CancerCompletedNCT00983424Phase 1
- Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic MelanomaCompletedNCT00970996Phase 1
- Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the LiverCompletedNCT00833807Phase 1
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal CavityCompletedNCT00825201Phase 1
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerWithdrawnNCT00748163Phase 2
- Hepatic Arterial Infusion (HAI) of AbraxaneCompletedNCT00732836Phase 1
- A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck CancerCompletedNCT00731380Phase 1
- Phase II Study of ABI-007 for Gastric CancerCompletedNCT00661167Phase 2
- Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)CompletedNCT00625573Phase 2
- A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast CancerTerminatedNCT00607438Phase 2
- Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerTerminatedNCT00521781Phase 2
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWithdrawnNCT00499291Not applicable
- A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic MelanomaCompletedNCT00483301Phase 2
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced CancersCompletedNCT00473720Phase 1
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
- Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT00466986Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
- ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaTerminatedNCT00407407Phase 1
- Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerWithdrawnNCT00397761Phase 2/3
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid CancersTerminatedNCT00337376Phase 1
- Dose Dense Abraxane in Adjuvant Chemotherapy for Breast CancerCompletedNCT00308178Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerCompletedNCT00284752Phase 2
- An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With CarboplatinCompletedNCT00274443Phase 2
- Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00107094Phase 1
- Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCompletedNCT00093119Phase 2
- ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic MelanomaCompletedNCT00081042Phase 2
- ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerCompletedNCT00077246Phase 1/2
- Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073723Phase 1/2
- Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
- ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
- A Trial of ABI-007 in Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00046423Phase 1
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1